MYCN and neuroblastoma: Further, we observed that highly aggressive MYCN-amplified NB tumors have higher expression of RAF1 and MAP2K2, which correlates with disease relapse or reoccurrence conditions in the Versteeg dataset (Figure 1G,H and Figure 2E,F).